Collectively, our data clearly demonstrate that TAT-hSPAR-C is necessary and sufficient for hSPAR-mediated cell proliferation inhibition and regulation on TRIM21/glutaimine-P27KIP1-mTOR axis in breast cancer cells. This evidence concerns the gene MTOR and breast carcinoma.